NCT05338879 Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma Status COMPLETED Phase N/A
NCT05326412 Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD Status COMPLETED Phase PHASE2
NCT05302297 Comparative Efficacy of Cemiplimab to Historical Standard of Care in France Status COMPLETED Phase N/A
NCT05293678 Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody/Ies in Adult Healthy Volunteers as Related to COVID-19 Status COMPLETED Phase PHASE1
NCT05291546 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants Status COMPLETED Phase PHASE1
NCT05265234 Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. Status UNKNOWN Phase PHASE4
NCT05259709 A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab Status RECRUITING Phase PHASE1
NCT05247866 Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis Status COMPLETED Phase PHASE4
NCT05246267 Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis Status RECRUITING Phase N/A
NCT05203380 Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase N/A
NCT05202288 Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers Status NOT_YET_RECRUITING Phase PHASE2
NCT05181683 COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers Status COMPLETED Phase PHASE1
NCT05169489 A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL) Status TERMINATED Phase PHASE1
NCT05164250 Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM) Status APPROVED_FOR_MARKETING Phase N/A
NCT05157997 Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail Status WITHDRAWN Phase PHASE1
NCT05137054 A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments Status RECRUITING Phase PHASE1
NCT05133531 A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE3